# EDGAR Filing Document

**Accession Number:** 0001790169
**File Stem:** 0000912282-25-001459
**Filing Date:** 2025-12
**Character Count:** 5418
**Document Hash:** f9616c7eb76e77d7e8c56c68468bd3e5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000912282-25-001459.hdr.sgml**: 20251223

**ACCESSION NUMBER**: 0000912282-25-001459

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251223

**DATE AS OF CHANGE**: 20251223

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Flora Growth Corp.
- **CENTRAL INDEX KEY:** 0001790169
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-93855
- **FILM NUMBER:** 251595815

**BUSINESS ADDRESS:**
- **STREET 1:** 3230 W. COMMERCIAL BOULEVARD
- **STREET 2:** SUITE 180
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33309
- **BUSINESS PHONE:** 416-861-2267

**MAIL ADDRESS:**
- **STREET 1:** 3230 W. COMMERCIAL BOULEVARD
- **STREET 2:** SUITE 180
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33309
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Vaiman Dany
- **CENTRAL INDEX KEY:** 0001955467

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**MAIL ADDRESS:**
- **STREET 1:** C/O FLORA GROWTH CORP.
- **STREET 2:** 3230 W. COMMERCIAL BOULEVARD, SUITE 180
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33309

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 3)**

**Flora Growth Corp.**

*(Name of Issuer)*

**Common Shares, no par value**

*(Title of Class of Securities)*

**339764102**

*(CUSIP Number)*

**Dany Vaiman**<br>3230 W. Commercial Blvd., Suite 180<br>Fort Lauderdale FL 33309<br>(416) 861-2267

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**12/19/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **339764102** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Vaiman Dany** | Name of reporting person<br>**Vaiman Dany** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**ISRAEL** | Citizenship or place of organization<br>**ISRAEL** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**263249.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**263249.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**263249.00** | Aggregate amount beneficially owned by each reporting person<br>**263249.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**23.8%** | Percent of class represented by amount in Row (11)<br>**23.8%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Shares, no par value

**(b) Name of Issuer:**
Flora Growth Corp.

**(c) Address of Issuer's Principal Executive Offices:**
3230 W. Commercial Blvd., Suite 180, Fort Lauderdale, FL, 33309

**Item 4. Purpose of Transaction**

On August 4, 2025, the Issuer effected a 39:1 reverse stock split.  On December 19, 2025, the Issuer granted to the Reporting Person 235,604 stock options, exercisable for shares of common stock of the Issuer at an exercise price of $7.31 per share.  The options vest in five equal installments subject to the Issuer's common stock meeting the following volume weighted average price ("VWAP") thresholds:  20% following VWAP of $10.97; 20% following VWAP of $14.62; 20% following VWAP of $18.28; 20% following VWAP of $21.93; and 20% following VWAP of $25.59.

**Item 5. Interest in Securities of the Issuer**

**(a)**
23.8%

**(b)**
Sole voting and dispositive power:  263,249; Shared voting and dispositive power:  0; Total:  263,249

**(c)**
See Item 4

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

N/A

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Vaiman Dany

**Signature:** /s/ Dany Vaiman

**Name/Title:** Vaiman Dany

**Date:** 12/22/2025